TY - JOUR
T1 - Analysis of a continuous series of 34 young patients with early-stage cervical cancer selected for a vaginal radical trachelectomy
T2 - Should "staging" conization be systematically performed before this procedure?
AU - Uzan, Catherine
AU - Gouy, Sebastien
AU - Desroque, Delphine
AU - Pomel, Christophe
AU - Duvillard, Pierre
AU - Balleyguier, Corrine
AU - Haie-Meder, Christine
AU - Morice, Philippe
PY - 2013/2/1
Y1 - 2013/2/1
N2 - Vaginal radical trachelectomy (VRT) is the most widely evaluated form of conservative management of young patients with early-stage (IB1) cervical cancer. Patients with nodal involvement or a tumor size greater than 2 cm are not eligible for such treatment. The aim of this study is to report the impact of a "staging" conization before VRT. Methods: This is a retrospective study of 34 patients potentially selected for VRT for a clinical and radiologic cervical tumor less than 2 cm. Among them, 28 underwent finally a VRT (20 of them having a previous conization before this procedure) and 6 patients with macroscopic cervical cancer, confirmed by punch biopsies, "eligible" for VRT (G2 cm) had undergone "staging" conization (without further VRT) to confirm the tumor size and lymphovascular space involvement (LVSI) status. Results: Six patients having "staging" conization before VRT had finally been deemed contraindications to VRT due to the presence of a histologically confirmed tumor greater than 2 cm and/or associated with multiple foci of LVSI. Among 28 patients who underwent VRT, 1 received adjuvant chemoradiation (this patient recurred and died of disease). Two patients treated with RVT (without postoperative treatment) recurred. Ten pregnancies (9 spontaneous and 1 induced) were observed in 9 patients. Among 4 patients with macroscopic "visible" tumor who do not underwent a "staging" conization before VRT, 2 recurred. Among 11 patients who underwent VRT and having LVSI, 3 recurred. Conclusions: These results suggest that if a conization is not performed initially, it should then be included among the staging procedures to select patients for VRT.
AB - Vaginal radical trachelectomy (VRT) is the most widely evaluated form of conservative management of young patients with early-stage (IB1) cervical cancer. Patients with nodal involvement or a tumor size greater than 2 cm are not eligible for such treatment. The aim of this study is to report the impact of a "staging" conization before VRT. Methods: This is a retrospective study of 34 patients potentially selected for VRT for a clinical and radiologic cervical tumor less than 2 cm. Among them, 28 underwent finally a VRT (20 of them having a previous conization before this procedure) and 6 patients with macroscopic cervical cancer, confirmed by punch biopsies, "eligible" for VRT (G2 cm) had undergone "staging" conization (without further VRT) to confirm the tumor size and lymphovascular space involvement (LVSI) status. Results: Six patients having "staging" conization before VRT had finally been deemed contraindications to VRT due to the presence of a histologically confirmed tumor greater than 2 cm and/or associated with multiple foci of LVSI. Among 28 patients who underwent VRT, 1 received adjuvant chemoradiation (this patient recurred and died of disease). Two patients treated with RVT (without postoperative treatment) recurred. Ten pregnancies (9 spontaneous and 1 induced) were observed in 9 patients. Among 4 patients with macroscopic "visible" tumor who do not underwent a "staging" conization before VRT, 2 recurred. Among 11 patients who underwent VRT and having LVSI, 3 recurred. Conclusions: These results suggest that if a conization is not performed initially, it should then be included among the staging procedures to select patients for VRT.
KW - Conization
KW - Conservative surgery
KW - Early-stage cervical cancer
KW - Radical trachelectomy
UR - http://www.scopus.com/inward/record.url?scp=84876274448&partnerID=8YFLogxK
U2 - 10.1097/IGC.0b013e31827ef759
DO - 10.1097/IGC.0b013e31827ef759
M3 - Article
C2 - 23358180
AN - SCOPUS:84876274448
SN - 1048-891X
VL - 23
SP - 331
EP - 336
JO - International Journal of Gynecological Cancer
JF - International Journal of Gynecological Cancer
IS - 2
ER -